 | • レポートコード：MRC2-11QY01951 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、116ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は20sプロテアソームのグローバル市場について調査・分析したレポートです。種類別（マリゾミブ、オプロゾミブ、カルフィルゾミブ、VPEA-002、その他）市場規模、用途別（結腸がん、リンパ腫、悪性神経膠腫、神経内分泌がん、卵巣がん、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別20sプロテアソームの競争状況、市場シェア ・世界の20sプロテアソーム市場：種類別市場規模 2015年-2020年（マリゾミブ、オプロゾミブ、カルフィルゾミブ、VPEA-002、その他） ・世界の20sプロテアソーム市場：種類別市場規模予測 2021年-2026年（マリゾミブ、オプロゾミブ、カルフィルゾミブ、VPEA-002、その他） ・世界の20sプロテアソーム市場：用途別市場規模 2015年-2020年（結腸がん、リンパ腫、悪性神経膠腫、神経内分泌がん、卵巣がん、その他） ・世界の20sプロテアソーム市場：用途別市場規模予測 2021年-2026年（結腸がん、リンパ腫、悪性神経膠腫、神経内分泌がん、卵巣がん、その他） ・北米の20sプロテアソーム市場分析：米国、カナダ ・ヨーロッパの20sプロテアソーム市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの20sプロテアソーム市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の20sプロテアソーム市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの20sプロテアソーム市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Amgen Inc、Celgene Corp ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Market Analysis and Insights: Global 20s Proteasome Market
The global 20s Proteasome market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global 20s Proteasome Scope and Market Size
20s Proteasome market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global 20s Proteasome market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the 20s Proteasome market is segmented into
Marizomib
Oprozomib
Carfilzomib
VPEA-002
Others
Segment by Application, the 20s Proteasome market is segmented into
Colon Cancer
Lymphoma
Malignant Glioma
Neuroendocrine Cancer
Ovarian Cancer
Others
Regional and Country-level Analysis
The 20s Proteasome market is analysed and market size information is provided by regions (countries).
The key regions covered in the 20s Proteasome market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and 20s Proteasome Market Share Analysis
20s Proteasome market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in 20s Proteasome business, the date to enter into the 20s Proteasome market, 20s Proteasome product introduction, recent developments, etc.
The major vendors covered:
Amgen Inc
Celgene Corp
…
1 Study Coverage
1.1 20s Proteasome Product Introduction
1.2 Market Segments
1.3 Key 20s Proteasome Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global 20s Proteasome Market Size Growth Rate by Type
1.4.2 Marizomib
1.4.3 Oprozomib
1.4.4 Carfilzomib
1.4.5 VPEA-002
1.4.6 Others
1.5 Market by Application
1.5.1 Global 20s Proteasome Market Size Growth Rate by Application
1.5.2 Colon Cancer
1.5.3 Lymphoma
1.5.4 Malignant Glioma
1.5.5 Neuroendocrine Cancer
1.5.6 Ovarian Cancer
1.5.7 Others
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global 20s Proteasome Market Size, Estimates and Forecasts
2.1.1 Global 20s Proteasome Revenue 2015-2026
2.1.2 Global 20s Proteasome Sales 2015-2026
2.2 Global 20s Proteasome, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global 20s Proteasome Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global 20s Proteasome Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global 20s Proteasome Competitor Landscape by Players
3.1 20s Proteasome Sales by Manufacturers
3.1.1 20s Proteasome Sales by Manufacturers (2015-2020)
3.1.2 20s Proteasome Sales Market Share by Manufacturers (2015-2020)
3.2 20s Proteasome Revenue by Manufacturers
3.2.1 20s Proteasome Revenue by Manufacturers (2015-2020)
3.2.2 20s Proteasome Revenue Share by Manufacturers (2015-2020)
3.2.3 Global 20s Proteasome Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by 20s Proteasome Revenue in 2019
3.2.5 Global 20s Proteasome Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 20s Proteasome Price by Manufacturers
3.4 20s Proteasome Manufacturing Base Distribution, Product Types
3.4.1 20s Proteasome Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers 20s Proteasome Product Type
3.4.3 Date of International Manufacturers Enter into 20s Proteasome Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global 20s Proteasome Market Size by Type (2015-2020)
4.1.1 Global 20s Proteasome Sales by Type (2015-2020)
4.1.2 Global 20s Proteasome Revenue by Type (2015-2020)
4.1.3 20s Proteasome Average Selling Price (ASP) by Type (2015-2026)
4.2 Global 20s Proteasome Market Size Forecast by Type (2021-2026)
4.2.1 Global 20s Proteasome Sales Forecast by Type (2021-2026)
4.2.2 Global 20s Proteasome Revenue Forecast by Type (2021-2026)
4.2.3 20s Proteasome Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global 20s Proteasome Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global 20s Proteasome Market Size by Application (2015-2020)
5.1.1 Global 20s Proteasome Sales by Application (2015-2020)
5.1.2 Global 20s Proteasome Revenue by Application (2015-2020)
5.1.3 20s Proteasome Price by Application (2015-2020)
5.2 20s Proteasome Market Size Forecast by Application (2021-2026)
5.2.1 Global 20s Proteasome Sales Forecast by Application (2021-2026)
5.2.2 Global 20s Proteasome Revenue Forecast by Application (2021-2026)
5.2.3 Global 20s Proteasome Price Forecast by Application (2021-2026)
6 North America
6.1 North America 20s Proteasome by Country
6.1.1 North America 20s Proteasome Sales by Country
6.1.2 North America 20s Proteasome Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America 20s Proteasome Market Facts & Figures by Type
6.3 North America 20s Proteasome Market Facts & Figures by Application
7 Europe
7.1 Europe 20s Proteasome by Country
7.1.1 Europe 20s Proteasome Sales by Country
7.1.2 Europe 20s Proteasome Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe 20s Proteasome Market Facts & Figures by Type
7.3 Europe 20s Proteasome Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific 20s Proteasome by Region
8.1.1 Asia Pacific 20s Proteasome Sales by Region
8.1.2 Asia Pacific 20s Proteasome Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific 20s Proteasome Market Facts & Figures by Type
8.3 Asia Pacific 20s Proteasome Market Facts & Figures by Application
9 Latin America
9.1 Latin America 20s Proteasome by Country
9.1.1 Latin America 20s Proteasome Sales by Country
9.1.2 Latin America 20s Proteasome Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America 20s Proteasome Market Facts & Figures by Type
9.3 Central & South America 20s Proteasome Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa 20s Proteasome by Country
10.1.1 Middle East and Africa 20s Proteasome Sales by Country
10.1.2 Middle East and Africa 20s Proteasome Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa 20s Proteasome Market Facts & Figures by Type
10.3 Middle East and Africa 20s Proteasome Market Facts & Figures by Application
11 Company Profiles
11.1 Amgen Inc
11.1.1 Amgen Inc Corporation Information
11.1.2 Amgen Inc Description and Business Overview
11.1.3 Amgen Inc Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Amgen Inc 20s Proteasome Products Offered
11.1.5 Amgen Inc Related Developments
11.2 Celgene Corp
11.2.1 Celgene Corp Corporation Information
11.2.2 Celgene Corp Description and Business Overview
11.2.3 Celgene Corp Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Celgene Corp 20s Proteasome Products Offered
11.2.5 Celgene Corp Related Developments
11.1 Amgen Inc
11.1.1 Amgen Inc Corporation Information
11.1.2 Amgen Inc Description and Business Overview
11.1.3 Amgen Inc Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Amgen Inc 20s Proteasome Products Offered
11.1.5 Amgen Inc Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 20s Proteasome Market Estimates and Projections by Region
12.1.1 Global 20s Proteasome Sales Forecast by Regions 2021-2026
12.1.2 Global 20s Proteasome Revenue Forecast by Regions 2021-2026
12.2 North America 20s Proteasome Market Size Forecast (2021-2026)
12.2.1 North America: 20s Proteasome Sales Forecast (2021-2026)
12.2.2 North America: 20s Proteasome Revenue Forecast (2021-2026)
12.2.3 North America: 20s Proteasome Market Size Forecast by Country (2021-2026)
12.3 Europe 20s Proteasome Market Size Forecast (2021-2026)
12.3.1 Europe: 20s Proteasome Sales Forecast (2021-2026)
12.3.2 Europe: 20s Proteasome Revenue Forecast (2021-2026)
12.3.3 Europe: 20s Proteasome Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific 20s Proteasome Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: 20s Proteasome Sales Forecast (2021-2026)
12.4.2 Asia Pacific: 20s Proteasome Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: 20s Proteasome Market Size Forecast by Region (2021-2026)
12.5 Latin America 20s Proteasome Market Size Forecast (2021-2026)
12.5.1 Latin America: 20s Proteasome Sales Forecast (2021-2026)
12.5.2 Latin America: 20s Proteasome Revenue Forecast (2021-2026)
12.5.3 Latin America: 20s Proteasome Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa 20s Proteasome Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: 20s Proteasome Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: 20s Proteasome Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: 20s Proteasome Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key 20s Proteasome Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 20s Proteasome Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. 20s Proteasome Market Segments
Table 2. Ranking of Global Top 20s Proteasome Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global 20s Proteasome Market Size Growth Rate by Type 2020-2026 (K Pcs) & (US$ Million)
Table 4. Major Manufacturers of Marizomib
Table 5. Major Manufacturers of Oprozomib
Table 6. Major Manufacturers of Carfilzomib
Table 7. Major Manufacturers of VPEA-002
Table 8. Major Manufacturers of Others
Table 9. Global 20s Proteasome Market Size Growth Rate by Application 2020-2026 (K Pcs)
Table 10. Global 20s Proteasome Market Size by Region (K Pcs) & (US$ Million): 2020 VS 2026
Table 11. Global 20s Proteasome Sales by Regions 2015-2020 (K Pcs)
Table 12. Global 20s Proteasome Sales Market Share by Regions (2015-2020)
Table 13. Global 20s Proteasome Revenue by Regions 2015-2020 (US$ Million)
Table 14. Global 20s Proteasome Sales by Manufacturers (2015-2020) (K Pcs)
Table 15. Global 20s Proteasome Sales Share by Manufacturers (2015-2020)
Table 16. Global 20s Proteasome Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 17. Global 20s Proteasome by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in 20s Proteasome as of 2019)
Table 18. 20s Proteasome Revenue by Manufacturers (2015-2020) (US$ Million)
Table 19. 20s Proteasome Revenue Share by Manufacturers (2015-2020)
Table 20. Key Manufacturers 20s Proteasome Price (2015-2020) (USD/Pcs)
Table 21. 20s Proteasome Manufacturers Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers 20s Proteasome Product Type
Table 23. Date of International Manufacturers Enter into 20s Proteasome Market
Table 24. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 25. Global 20s Proteasome Sales by Type (2015-2020) (K Pcs)
Table 26. Global 20s Proteasome Sales Share by Type (2015-2020)
Table 27. Global 20s Proteasome Revenue by Type (2015-2020) (US$ Million)
Table 28. Global 20s Proteasome Revenue Share by Type (2015-2020)
Table 29. 20s Proteasome Average Selling Price (ASP) by Type 2015-2020 (USD/Pcs)
Table 30. Global 20s Proteasome Sales by Application (2015-2020) (K Pcs)
Table 31. Global 20s Proteasome Sales Share by Application (2015-2020)
Table 32. North America 20s Proteasome Sales by Country (2015-2020) (K Pcs)
Table 33. North America 20s Proteasome Sales Market Share by Country (2015-2020)
Table 34. North America 20s Proteasome Revenue by Country (2015-2020) (US$ Million)
Table 35. North America 20s Proteasome Revenue Market Share by Country (2015-2020)
Table 36. North America 20s Proteasome Sales by Type (2015-2020) (K Pcs)
Table 37. North America 20s Proteasome Sales Market Share by Type (2015-2020)
Table 38. North America 20s Proteasome Sales by Application (2015-2020) (K Pcs)
Table 39. North America 20s Proteasome Sales Market Share by Application (2015-2020)
Table 40. Europe 20s Proteasome Sales by Country (2015-2020) (K Pcs)
Table 41. Europe 20s Proteasome Sales Market Share by Country (2015-2020)
Table 42. Europe 20s Proteasome Revenue by Country (2015-2020) (US$ Million)
Table 43. Europe 20s Proteasome Revenue Market Share by Country (2015-2020)
Table 44. Europe 20s Proteasome Sales by Type (2015-2020) (K Pcs)
Table 45. Europe 20s Proteasome Sales Market Share by Type (2015-2020)
Table 46. Europe 20s Proteasome Sales by Application (2015-2020) (K Pcs)
Table 47. Europe 20s Proteasome Sales Market Share by Application (2015-2020)
Table 48. Asia Pacific 20s Proteasome Sales by Region (2015-2020) (K Pcs)
Table 49. Asia Pacific 20s Proteasome Sales Market Share by Region (2015-2020)
Table 50. Asia Pacific 20s Proteasome Revenue by Region (2015-2020) (US$ Million)
Table 51. Asia Pacific 20s Proteasome Revenue Market Share by Region (2015-2020)
Table 52. Asia Pacific 20s Proteasome Sales by Type (2015-2020) (K Pcs)
Table 53. Asia Pacific 20s Proteasome Sales Market Share by Type (2015-2020)
Table 54. Asia Pacific 20s Proteasome Sales by Application (2015-2020) (K Pcs)
Table 55. Asia Pacific 20s Proteasome Sales Market Share by Application (2015-2020)
Table 56. Latin America 20s Proteasome Sales by Country (2015-2020) (K Pcs)
Table 57. Latin America 20s Proteasome Sales Market Share by Country (2015-2020)
Table 58. Latin Americaa 20s Proteasome Revenue by Country (2015-2020) (US$ Million)
Table 59. Latin America 20s Proteasome Revenue Market Share by Country (2015-2020)
Table 60. Latin America 20s Proteasome Sales by Type (2015-2020) (K Pcs)
Table 61. Latin America 20s Proteasome Sales Market Share by Type (2015-2020)
Table 62. Latin America 20s Proteasome Sales by Application (2015-2020) (K Pcs)
Table 63. Latin America 20s Proteasome Sales Market Share by Application (2015-2020)
Table 64. Middle East and Africa 20s Proteasome Sales by Country (2015-2020) (K Pcs)
Table 65. Middle East and Africa 20s Proteasome Sales Market Share by Country (2015-2020)
Table 66. Middle East and Africa 20s Proteasome Revenue by Country (2015-2020) (US$ Million)
Table 67. Middle East and Africa 20s Proteasome Revenue Market Share by Country (2015-2020)
Table 68. Middle East and Africa 20s Proteasome Sales by Type (2015-2020) (K Pcs)
Table 69. Middle East and Africa 20s Proteasome Sales Market Share by Type (2015-2020)
Table 70. Middle East and Africa 20s Proteasome Sales by Application (2015-2020) (K Pcs)
Table 71. Middle East and Africa 20s Proteasome Sales Market Share by Application (2015-2020)
Table 72. Amgen Inc Corporation Information
Table 73. Amgen Inc Description and Major Businesses
Table 74. Amgen Inc 20s Proteasome Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 75. Amgen Inc Product
Table 76. Amgen Inc Recent Development
Table 77. Celgene Corp Corporation Information
Table 78. Celgene Corp Description and Major Businesses
Table 79. Celgene Corp 20s Proteasome Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 80. Celgene Corp Product
Table 81. Celgene Corp Recent Development
Table 82. Global 20s Proteasome Sales Forecast by Regions (2021-2026) (K Pcs)
Table 83. Global 20s Proteasome Sales Market Share Forecast by Regions (2021-2026)
Table 84. Global 20s Proteasome Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 85. Global 20s Proteasome Revenue Market Share Forecast by Regions (2021-2026)
Table 86. North America: 20s Proteasome Sales Forecast by Country (2021-2026) (K Pcs)
Table 87. North America: 20s Proteasome Revenue Forecast by Country (2021-2026) (US$ Million)
Table 88. Europe: 20s Proteasome Sales Forecast by Country (2021-2026) (K Pcs)
Table 89. Europe: 20s Proteasome Revenue Forecast by Country (2021-2026) (US$ Million)
Table 90. Asia Pacific: 20s Proteasome Sales Forecast by Region (2021-2026) (K Pcs)
Table 91. Asia Pacific: 20s Proteasome Revenue Forecast by Region (2021-2026) (US$ Million)
Table 92. Latin America: 20s Proteasome Sales Forecast by Country (2021-2026) (K Pcs)
Table 93. Latin America: 20s Proteasome Revenue Forecast by Country (2021-2026) (US$ Million)
Table 94. Middle East and Africa: 20s Proteasome Sales Forecast by Country (2021-2026) (K Pcs)
Table 95. Middle East and Africa: 20s Proteasome Revenue Forecast by Country (2021-2026) (US$ Million)
Table 96. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 97. Key Challenges
Table 98. Market Risks
Table 99. Main Points Interviewed from Key 20s Proteasome Players
Table 100. 20s Proteasome Customers List
Table 101. 20s Proteasome Distributors List
Table 102. Research Programs/Design for This Report
Table 103. Key Data Information from Secondary Sources
Table 104. Key Data Information from Primary Sources
List of Figures
Figure 1. 20s Proteasome Product Picture
Figure 2. Global 20s Proteasome Sales Market Share by Type in 2020 & 2026
Figure 3. Marizomib Product Picture
Figure 4. Oprozomib Product Picture
Figure 5. Carfilzomib Product Picture
Figure 6. VPEA-002 Product Picture
Figure 7. Others Product Picture
Figure 8. Global 20s Proteasome Sales Market Share by Application in 2020 & 2026
Figure 9. Colon Cancer
Figure 10. Lymphoma
Figure 11. Malignant Glioma
Figure 12. Neuroendocrine Cancer
Figure 13. Ovarian Cancer
Figure 14. Others
Figure 15. 20s Proteasome Report Years Considered
Figure 16. Global 20s Proteasome Market Size 2015-2026 (US$ Million)
Figure 17. Global 20s Proteasome Sales 2015-2026 (K Pcs)
Figure 18. Global 20s Proteasome Market Size Market Share by Region: 2020 Versus 2026
Figure 19. Global 20s Proteasome Sales Market Share by Region (2015-2020)
Figure 20. Global 20s Proteasome Sales Market Share by Region in 2019
Figure 21. Global 20s Proteasome Revenue Market Share by Region (2015-2020)
Figure 22. Global 20s Proteasome Revenue Market Share by Region in 2019
Figure 23. Global 20s Proteasome Sales Share by Manufacturer in 2019
Figure 24. The Top 10 and 5 Players Market Share by 20s Proteasome Revenue in 2019
Figure 25. 20s Proteasome Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 26. Global 20s Proteasome Sales Market Share by Type (2015-2020)
Figure 27. Global 20s Proteasome Sales Market Share by Type in 2019
Figure 28. Global 20s Proteasome Revenue Market Share by Type (2015-2020)
Figure 29. Global 20s Proteasome Revenue Market Share by Type in 2019
Figure 30. Global 20s Proteasome Market Share by Price Range (2015-2020)
Figure 31. Global 20s Proteasome Sales Market Share by Application (2015-2020)
Figure 32. Global 20s Proteasome Sales Market Share by Application in 2019
Figure 33. Global 20s Proteasome Revenue Market Share by Application (2015-2020)
Figure 34. Global 20s Proteasome Revenue Market Share by Application in 2019
Figure 35. North America 20s Proteasome Sales Growth Rate 2015-2020 (K Pcs)
Figure 36. North America 20s Proteasome Revenue Growth Rate 2015-2020 (US$ Million)
Figure 37. North America 20s Proteasome Sales Market Share by Country in 2019
Figure 38. North America 20s Proteasome Revenue Market Share by Country in 2019
Figure 39. U.S. 20s Proteasome Sales Growth Rate (2015-2020) (K Pcs)
Figure 40. U.S. 20s Proteasome Revenue Growth Rate (2015-2020) (US$ Million)
Figure 41. Canada 20s Proteasome Sales Growth Rate (2015-2020) (K Pcs)
Figure 42. Canada 20s Proteasome Revenue Growth Rate (2015-2020) (US$ Million)
Figure 43. North America 20s Proteasome Market Share by Type in 2019
Figure 44. North America 20s Proteasome Market Share by Application in 2019
Figure 45. Europe 20s Proteasome Sales Growth Rate 2015-2020 (K Pcs)
Figure 46. Europe 20s Proteasome Revenue Growth Rate 2015-2020 (US$ Million)
Figure 47. Europe 20s Proteasome Sales Market Share by Country in 2019
Figure 48. Europe 20s Proteasome Revenue Market Share by Country in 2019
Figure 49. Germany 20s Proteasome Sales Growth Rate (2015-2020) (K Pcs)
Figure 50. Germany 20s Proteasome Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. France 20s Proteasome Sales Growth Rate (2015-2020) (K Pcs)
Figure 52. France 20s Proteasome Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. U.K. 20s Proteasome Sales Growth Rate (2015-2020) (K Pcs)
Figure 54. U.K. 20s Proteasome Revenue Growth Rate (2015-2020) (US$ Million)
Figure 55. Italy 20s Proteasome Sales Growth Rate (2015-2020) (K Pcs)
Figure 56. Italy 20s Proteasome Revenue Growth Rate (2015-2020) (US$ Million)
Figure 57. Russia 20s Proteasome Sales Growth Rate (2015-2020) (K Pcs)
Figure 58. Russia 20s Proteasome Revenue Growth Rate (2015-2020) (US$ Million)
Figure 59. Europe 20s Proteasome Market Share by Type in 2019
Figure 60. Europe 20s Proteasome Market Share by Application in 2019
Figure 61. Asia Pacific 20s Proteasome Sales Growth Rate 2015-2020 (K Pcs)
Figure 62. Asia Pacific 20s Proteasome Revenue Growth Rate 2015-2020 (US$ Million)
Figure 63. Asia Pacific 20s Proteasome Sales Market Share by Region in 2019
Figure 64. Asia Pacific 20s Proteasome Revenue Market Share by Region in 2019
Figure 65. China 20s Proteasome Sales Growth Rate (2015-2020) (K Pcs)
Figure 66. China 20s Proteasome Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. Japan 20s Proteasome Sales Growth Rate (2015-2020) (K Pcs)
Figure 68. Japan 20s Proteasome Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. South Korea 20s Proteasome Sales Growth Rate (2015-2020) (K Pcs)
Figure 70. South Korea 20s Proteasome Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. India 20s Proteasome Sales Growth Rate (2015-2020) (K Pcs)
Figure 72. India 20s Proteasome Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Australia 20s Proteasome Sales Growth Rate (2015-2020) (K Pcs)
Figure 74. Australia 20s Proteasome Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Taiwan 20s Proteasome Sales Growth Rate (2015-2020) (K Pcs)
Figure 76. Taiwan 20s Proteasome Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Indonesia 20s Proteasome Sales Growth Rate (2015-2020) (K Pcs)
Figure 78. Indonesia 20s Proteasome Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Thailand 20s Proteasome Sales Growth Rate (2015-2020) (K Pcs)
Figure 80. Thailand 20s Proteasome Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Malaysia 20s Proteasome Sales Growth Rate (2015-2020) (K Pcs)
Figure 82. Malaysia 20s Proteasome Revenue Growth Rate (2015-2020) (US$ Million)
Figure 83. Philippines 20s Proteasome Sales Growth Rate (2015-2020) (K Pcs)
Figure 84. Philippines 20s Proteasome Revenue Growth Rate (2015-2020) (US$ Million)
Figure 85. Vietnam 20s Proteasome Sales Growth Rate (2015-2020) (K Pcs)
Figure 86. Vietnam 20s Proteasome Revenue Growth Rate (2015-2020) (US$ Million)
Figure 87. Asia Pacific 20s Proteasome Market Share by Type in 2019
Figure 88. Asia Pacific 20s Proteasome Market Share by Application in 2019
Figure 89. Latin America 20s Proteasome Sales Growth Rate 2015-2020 (K Pcs)
Figure 90. Latin America 20s Proteasome Revenue Growth Rate 2015-2020 (US$ Million)
Figure 91. Latin America 20s Proteasome Sales Market Share by Country in 2019
Figure 92. Latin America 20s Proteasome Revenue Market Share by Country in 2019
Figure 93. Mexico 20s Proteasome Sales Growth Rate (2015-2020) (K Pcs)
Figure 94. Mexico 20s Proteasome Revenue Growth Rate (2015-2020) (US$ Million)
Figure 95. Brazil 20s Proteasome Sales Growth Rate (2015-2020) (K Pcs)
Figure 96. Brazil 20s Proteasome Revenue Growth Rate (2015-2020) (US$ Million)
Figure 97. Argentina 20s Proteasome Sales Growth Rate (2015-2020) (K Pcs)
Figure 98. Argentina 20s Proteasome Revenue Growth Rate (2015-2020) (US$ Million)
Figure 99. Latin America 20s Proteasome Market Share by Type in 2019
Figure 100. Latin America 20s Proteasome Market Share by Application in 2019
Figure 101. Middle East and Africa 20s Proteasome Sales Growth Rate 2015-2020 (K Pcs)
Figure 102. Middle East and Africa 20s Proteasome Revenue Growth Rate 2015-2020 (US$ Million)
Figure 103. Middle East and Africa 20s Proteasome Sales Market Share by Country in 2019
Figure 104. Middle East and Africa 20s Proteasome Revenue Market Share by Country in 2019
Figure 105. Turkey 20s Proteasome Sales Growth Rate (2015-2020) (K Pcs)
Figure 106. Turkey 20s Proteasome Revenue Growth Rate (2015-2020) (US$ Million)
Figure 107. Saudi Arabia 20s Proteasome Sales Growth Rate (2015-2020) (K Pcs)
Figure 108. Saudi Arabia 20s Proteasome Revenue Growth Rate (2015-2020) (US$ Million)
Figure 109. U.A.E 20s Proteasome Sales Growth Rate (2015-2020) (K Pcs)
Figure 110. U.A.E 20s Proteasome Revenue Growth Rate (2015-2020) (US$ Million)
Figure 111. Middle East and Africa 20s Proteasome Market Share by Type in 2019
Figure 112. Middle East and Africa 20s Proteasome Market Share by Application in 2019
Figure 113. North America 20s Proteasome Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 114. North America 20s Proteasome Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 115. Europe 20s Proteasome Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 116. Europe 20s Proteasome Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 117. Asia Pacific 20s Proteasome Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 118. Asia Pacific 20s Proteasome Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 119. Latin America 20s Proteasome Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 120. Latin America 20s Proteasome Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 121. Middle East and Africa 20s Proteasome Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 122. Middle East and Africa 20s Proteasome Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 123. Porter's Five Forces Analysis
Figure 124. Channels of Distribution
Figure 125. Distributors Profiles
Figure 126. Bottom-up and Top-down Approaches for This Report
Figure 127. Data Triangulation
Figure 128. Key Executives Interviewed
ユビキチンプロテアソームの世界市場（～2026年） Market Analysis and Insights: Global Ubiquitin Proteasome Market The global Ubiquitin Proteasome market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Ubiquitin Proteasome Scope and Market Size Ubiquitin Proteasome market is…- プロテアソーム阻害剤の世界市場（～2026年） Proteasome inhibitors are drugs that block the action of proteasomes, cellular complexes that break down proteins. Proteasome inhibitors are being studied in the treatment of cancer and are used in treating multiple myeloma. Market Analysis and Insights: Global Proteasome Inhibitors Market The globa…
- 結腸がんの世界市場（～2026年） Colon cancer is the cancer of large intestine which form the lower part of the digestive system. The disease usually begins with a small, benign clusters of cells known as adenomatous polyps. If left untreated, these polyps may result into colon cancer. Therefore, regular screening for polyps throug…
- 卵巣がん遺伝子治療の世界市場（～2026年） Ovarian cancer occurs and arises from several types of cells within the ovary, and it has the lowest survival rate of all gynecological cancers. Among many types, epithelial ovarian cancer (EOC) is the most common ovarian cancer, whereas ovarian low malignant potential tumor (OLMPT), germ cell tumor…
- 卵巣がんの世界市場（～2026年） Ovarian cancer is a type of cancer that begins in the ovaries. Ovarian cancer is the most common type of cancer among women. Epithelial tumor, stromal tumor and germ cell tumors are the type of ovarian cancer. North America dominates the global market for ovarian cancer due to large number of aging …